Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BSX

Boston Scientific Corp

Mar 24 • 09:59AM ET

102.08

Dollar change +1.39
Percentage change 1.38	%

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO SPY IVV VUG XLV IHI VHT IWD IVW

Scroll to Statements

Index	S&P 500	P/E	81.83	EPS (ttm)	1.25	Insider Own	0.47%	Shs Outstand	1.47B	Perf Week	3.22%
Market Cap	150.99B	Forward P/E	31.28	EPS next Y	3.26	Insider Trans	-9.86%	Shs Float	1.47B	Perf Month	-2.30%
Income	1.85B	PEG	6.03	EPS next Q	0.67	Inst Own	91.99%	Short Float	0.87%	Perf Quarter	15.96%
Sales	16.75B	P/S	9.02	EPS this Y	13.94%	Inst Trans	1.34%	Short Ratio	1.93	Perf Half Y	21.95%
Book/sh	14.76	P/B	6.91	EPS next Y	14.10%	ROA	4.97%	Short Interest	12.87M	Perf Year	51.37%
Cash/sh	0.35	P/C	287.60	EPS next 5Y	13.58%	ROE	9.03%	52W Range	66.80 - 107.17	Perf YTD	14.29%
Dividend Est.	-	P/FCF	57.08	EPS past 5Y	-17.84%	ROI	5.95%	52W High	-4.75%	Beta	0.74
Dividend TTM	-	Quick Ratio	0.64	Sales past 5Y	9.77%	Gross Margin	61.44%	52W Low	52.82%	ATR (14)	2.42
Dividend Ex-Date	-	Current Ratio	1.08	EPS Y/Y TTM	16.84%	Oper. Margin	15.85%	RSI (14)	54.75	Volatility	2.14% 2.72%
Employees	53000	Debt/Eq	0.52	Sales Y/Y TTM	17.60%	Profit Margin	11.07%	Recom	1.54	Target Price	119.25
Option/Short	Yes / Yes	LT Debt/Eq	0.43	EPS Q/Q	11.28%	Payout	0.00%	Rel Volume	0.48	Prev Close	100.69
Sales Surprise	3.18%	EPS Surprise	6.53%	Sales Q/Q	22.44%	Earnings	Feb 05 BMO	Avg Volume	6.67M	Price	102.08
SMA20	2.00%	SMA50	0.57%	SMA200	16.53%	Trades		Volume	385,882	Change	1.38%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy	$108
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55
Dec-10-21	Initiated	RBC Capital Mkts	Outperform	$51
May-26-21	Downgrade	Needham	Buy → Hold
May-25-21	Initiated	Barclays	Overweight	$51
Apr-15-21	Initiated	Atlantic Equities	Overweight	$52

Show Previous Ratings

Today 08:45AM	Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains (Zacks)
Mar-22-25 08:00AM	GE Aerospace Leads Five Stocks Near Buy Points With This Bullish Trait (Investor's Business Daily)
Mar-21-25 12:53PM	Revvity Stock Tumbles Despite Expanding Genomics England Alliance (Zacks)
12:36PM	PODD Stock Gains Following the Launch of Omnipod 5 in Australia (Zacks)
12:15PM	Should You Consider Retaining ZBH Stock in Your Portfolio Now? (Zacks)
08:22AM	Loading…
08:22AM	GMED Stock Jumps 41.8% in a Year: What's Behind the Rally? (Zacks)
08:19AM	DGX Stock Set to Benefit From New Google Cloud Partnership (Zacks)
Mar-20-25 01:27PM	HealthEquity Stock Tumbles Despite the Launch of Assist Benefits Suite (Zacks)
01:05PM	Here's Why You Should Retain PacBio Stock in Your Portfolio Now (Zacks)
12:52PM	GEHC Stock Gains Following Cardiology Solutions Portfolio Expansion (Zacks)
12:41PM	PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5 (Zacks)
11:46AM	New Product Launches to Support HOLX Stock Amid Macro Issues (Zacks)
09:44AM	TMO Stock Set to Gain From the Launch of New Vulcan Automated Lab (Zacks)
09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
Mar-19-25 12:54PM	GEHC Stock Gains in Pre-Market Following Tie-Up Expansion With NVIDIA (Zacks)
12:35PM	Loading…
12:35PM	HQY Stock Falls as Q4 Earnings Miss Estimates, Revenues Up Y/Y (Zacks)
11:32AM	Here's Why you Should Retain Nevro Stock in Your Portfolio Now (Zacks)
11:22AM	Here's Why You Should Retain AMED Stock in Your Portfolio Now (Zacks)
10:02AM	Should You Hold Globus Medical Stock in Your Portfolio Now? (Zacks)
09:18AM	TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology (Zacks)
Mar-18-25 06:13PM	Is Boston Scientific Corporation (BSX) the Top Stock to Buy According to Marshall Wace LLP? (Insider Monkey)
06:00PM	Boston Scientific (BSX) Gains As Market Dips: What You Should Know (Zacks)
07:00AM	The best areas in the market for retail investors (Yahoo Finance Video)
Mar-17-25 06:15PM	Boston Scientific (BSX) Outpaces Stock Market Gains: What You Should Know (Zacks)
Mar-13-25 05:04AM	Q4 Earnings Roundup: CooperCompanies (NASDAQ:COO) And The Rest Of The Medical Devices & Supplies - Diversified Segment (StockStory)
Mar-12-25 09:45AM	Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term (Zacks)
Mar-11-25 06:00PM	Boston Scientific (BSX) Gains As Market Dips: What You Should Know (Zacks)
Mar-10-25 05:08AM	2 Reasons to Like BSX (and 1 Not So Much) (StockStory) -5.04%
Mar-07-25 11:30AM	Boston Scientific (BSX) Down 4% Since Last Earnings Report: Can It Rebound? (Zacks)
08:17AM	Q4 2024 Elutia Inc Earnings Call (Thomson Reuters StreetEvents)
02:15AM	Loading…
02:15AM	Elutia Inc (ELUT) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Product Growth ... (GuruFocus.com)
Mar-06-25 09:00AM	Is Trending Stock Boston Scientific Corporation (BSX) a Buy Now? (Zacks)
07:11AM	4C Medical raises up to $175m to advance AltaValve System through trials (Medical Device Network)
01:20AM	Boston Scientific leads $175M investment in 4C Medical (MedTech Dive)
Mar-05-25 06:00PM	Boston Scientific (BSX) Gains But Lags Market: What You Should Know (Zacks)
09:30AM	Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? (Zacks)
Mar-04-25 03:04PM	Alcon Stock Gets Relative Strength Rating Lift (Investor's Business Daily)
05:05AM	Boston Scientific to acquire Tivus system developer SoniVie (Medical Device Network)
05:05AM	Boston Scientific buys Tivus system developer SoniVie in $540m deal (Medical Device Network)
Mar-03-25 09:50AM	Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term (Zacks)
06:58AM	Boston Scientific announces agreement to acquire SoniVie Ltd. (PR Newswire)
06:18AM	Boston Scientific to buy Sonivie for up to $540M (MedTech Dive)
Feb-28-25 04:04AM	Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest (StockStory)
Feb-27-25 06:00PM	Boston Scientific (BSX) Stock Moves -0.75%: What You Should Know (Zacks)
10:05AM	Boston Scientific Corporation (BSX): Among Stocks to Invest In from Israel Englanders Portfolio (Insider Monkey)
Feb-26-25 04:15PM	Boston Scientific announces completion of 1.5 billion offering of senior notes (PR Newswire)
Feb-25-25 02:52PM	Medtronic Stock Gets IBD Rating Lift (Investor's Business Daily)
04:02AM	Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment (StockStory)
Feb-24-25 09:40AM	Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year? (Zacks)
04:01AM	Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks (StockStory)
Feb-21-25 09:35PM	Boston Scientific announces pricing of 1.5 billion of senior notes (PR Newswire)
Feb-19-25 10:01AM	Solid Company Fundamentals Lifted Boston Scientific Corporation (BSX) (Insider Monkey)
08:07AM	Baxter Earnings: What To Look For From BAX (StockStory)
08:00AM	Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference (PR Newswire)
Feb-17-25 11:31AM	Boston Scientific bags CE marking for Farapulse catheter and software (Medical Device Network)
Feb-14-25 09:41AM	Boston Scientific Corporation (BSX): Among the Best Momentum Stocks to Buy According to Hedge Funds (Insider Monkey)
08:00AM	J&Js High Hopes for Heart-Rhythm Device Grounded by Safety Concerns (The Wall Street Journal)
Feb-12-25 09:19AM	Why Boston Scientific Corporation (BSX) is the Best Medical Device Stock to Buy (Insider Monkey)
08:05AM	What To Expect From Baxters (BAX) Q4 Earnings (StockStory)
Feb-10-25 12:55PM	Globus Medical strengthens SCS market position with $250m Nevro deal (Medical Device Network)
04:04AM	Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX) (StockStory)
Feb-07-25 12:00PM	Boston Scientific (BSX) is a Great Momentum Stock: Should You Buy? (Zacks)
09:40AM	Has Boston Scientific (BSX) Outpaced Other Medical Stocks This Year? (Zacks)
Feb-06-25 11:42AM	Farapulse boosts Boston Scientifics Q4 electrophysiology sales by 172% (Medical Device Network)
09:45AM	Here's Why Boston Scientific (BSX) is a Strong Growth Stock (Zacks)
02:06AM	Boston Scientific Corp (BSX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strong ... (GuruFocus.com)
12:40AM	Q4 2024 Boston Scientific Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-05-25 04:32PM	How Boston Sci Leaned On Its New Heart Device For A Fourth-Quarter Beat (Investor's Business Daily)
03:43PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
09:30AM	Boston Scientific (BSX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:57AM	Boston Scientific Beats Its Own Fourth-Quarter Guidance On Cardiovascular Strength (Investor's Business Daily)
07:45AM	Boston Scientific (BSX) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
07:24AM	Boston Scientific reports above-consensus Q4 results, provides outlook (Investing.com)
06:56AM	Boston Scientific closes its year of PFA on a high note (MedTech Dive)
06:50AM	Boston Scientific (NYSE:BSX) Reports Bullish Q4, Guides for Strong Sales Next Quarter (StockStory)
06:49AM	Boston Scientific: Q4 Earnings Snapshot (Associated Press Finance)
06:37AM	Boston Scientific announces results for fourth quarter and full year 2024 (PR Newswire)
Feb-03-25 01:06PM	TD Cowen Raises Boston Scientific Corporation (BSX) Target to $115, Reaffirms Buy Rating Ahead of Q4 Results (Insider Monkey)
Feb-01-25 09:05AM	Boston Scientific price target raised to $119 from $101 at Raymond James (TipRanks)
Jan-31-25 09:15AM	What Analyst Projections for Key Metrics Reveal About Boston Scientific (BSX) Q4 Earnings (Zacks)
Jan-29-25 10:01AM	Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy? (Zacks)
Jan-28-25 06:09AM	US pulsed field ablation market revenue exceeds $500m in 2024 (Medical Device Network)
Jan-27-25 06:00PM	Boston Scientific (BSX) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
07:49AM	Is Boston Scientific (BSX) Among the Best Fundamental Stocks to Buy Now? (Insider Monkey)
06:27AM	Doctors expect Boston Scientific to lead PFA race, survey finds (MedTech Dive)
Jan-24-25 12:03PM	Boston Scientific Corp (BSX): AI-Driven Innovation and Barclays Bullish $111 Price Target (Insider Monkey)
Jan-23-25 06:15PM	Boston Scientific (BSX) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-21-25 05:21PM	Is Boston Scientific (BSX) Among Billionaire Steve Cohens Top Stock Picks? (Insider Monkey)
06:38AM	Boston Scientific study meets goals for PFA in persistent AFib (MedTech Dive)
Jan-20-25 08:06AM	Boston Scientific sees success in PFA device trial (Clinical Trials Arena)
Jan-17-25 06:00PM	Boston Scientific (BSX) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
Jan-16-25 05:33PM	Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation (PR Newswire)
Jan-15-25 06:10AM	Boston Scientific Jumps Ahead of Earnings (FX Empire)
Jan-14-25 11:30PM	Boston Scientific ups PFA forecast, targets market leadership (MedTech Dive)
Jan-13-25 06:15PM	Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors (Zacks)
04:01PM	Why Boston Scientific (BSX) is Skyrocketing in 2025? (Insider Monkey)
Jan-10-25 01:13PM	Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific (CNBC TV)
Jan-09-25 05:52AM	5 medtech trends to watch in 2025 (MedTech Dive)
05:16AM	Boston Scientific to acquire remaining ownership stake in Bolt Medical for $664m (Medical Device Network)
04:29AM	Boston Scientific Completes Acquisition of Bolt Medical, Bolstering Cardiovascular Portfolio (GuruFocus.com)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
VANCE BROWN	Officer	Mar 21 '25	Proposed Sale	100.85	4,826	486,702		Mar 21 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Option Exercise	37.50	5,949	223,088	8,063	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Sale	104.97	7,149	750,465	914	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 04 '25	Sale	104.63	482	50,432	432	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Option Exercise	42.16	7,218	304,311	11,519	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 01 '25	Option Exercise	0.00	837	0	2,469	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Sale	101.13	9,887	999,872	1,632	Mar 03 04:11 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 24 '25	Sale	104.25	4,675	487,369	28,454	Feb 25 04:41 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 25 '25	Sale	104.00	2,688	279,552	25,766	Feb 25 04:41 PM
JEFFREY B MIRVISS	Officer	Feb 25 '25	Proposed Sale	104.00	2,688	279,552		Feb 25 04:02 PM
Zane Ellen M	Director	Feb 24 '25	Sale	104.23	13,586	1,416,134	34,944	Feb 24 04:08 PM
JEFFREY B MIRVISS	Officer	Feb 24 '25	Proposed Sale	104.25	4,675	487,369		Feb 24 04:01 PM
Zane Ellen M	Director	Feb 24 '25	Proposed Sale	104.23	13,586	1,416,088		Feb 24 11:30 AM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21 '25	Sale	104.64	4,826	504,993	45,845	Feb 21 04:15 PM
VANCE BROWN	Officer	Feb 21 '25	Proposed Sale	104.64	4,826	504,993		Feb 21 04:03 PM
Sorenson John Bradley	EVP, Global Operations	Feb 19 '25	Sale	105.19	3,303	347,443	20,991	Feb 19 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '25	Sale	104.41	2,657	277,417	24,294	Feb 19 04:23 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 19 '25	Sale	105.35	1,510	159,078	33,129	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Option Exercise	25.61	60,523	1,550,275	293,141	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Sale	105.24	67,333	7,086,111	225,808	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '25	Sale	104.57	17,530	1,833,184	232,618	Feb 19 04:23 PM
DANIEL BRENNAN	Officer	Feb 19 '25	Proposed Sale	105.24	67,333	7,086,109		Feb 19 04:05 PM
JEFFREY B MIRVISS	Officer	Feb 19 '25	Proposed Sale	105.35	1,510	159,078		Feb 19 04:01 PM
JOHN B SORENSON	Officer	Feb 19 '25	Proposed Sale	105.19	3,303	347,443		Feb 19 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 14 '25	Option Exercise	0.00	661	0	3,867	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 16 '25	Option Exercise	0.00	636	0	4,188	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 17 '25	Option Exercise	0.00	667	0	4,584	Feb 18 05:53 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Option Exercise	0.00	2,115	0	27,609	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '25	Option Exercise	0.00	1,273	0	26,716	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '25	Option Exercise	0.00	1,500	0	27,635	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Sale	106.31	1,201	127,678	25,443	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	1,123	0	13,702	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	106	0	1,650	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	990	0	14,362	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	85	0	1,697	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	1,000	0	15,071	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	100	0	1,767	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 14 '25	Option Exercise	0.00	2,776	0	32,477	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '25	Option Exercise	0.00	2,970	0	34,181	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '25	Option Exercise	0.00	3,334	0	36,160	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 14 '25	Option Exercise	0.00	16,524	0	1,643,475	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16 '25	Option Exercise	0.00	16,265	0	1,651,750	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17 '25	Option Exercise	0.00	18,334	0	1,662,219	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 14 '25	Option Exercise	0.00	4,362	0	179,108	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 16 '25	Option Exercise	0.00	3,960	0	181,078	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 17 '25	Option Exercise	0.00	4,167	0	183,439	Feb 18 05:52 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 14 '25	Option Exercise	0.00	3,172	0	20,935	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 16 '25	Option Exercise	0.00	2,546	0	21,947	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 17 '25	Option Exercise	0.00	2,834	0	23,550	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 14 '25	Option Exercise	0.00	1,850	0	50,101	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 16 '25	Option Exercise	0.00	1,839	0	51,045	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 17 '25	Option Exercise	0.00	1,000	0	51,155	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 14 '25	Option Exercise	0.00	4,362	0	247,700	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 16 '25	Option Exercise	0.00	4,243	0	249,833	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 17 '25	Option Exercise	0.00	4,584	0	252,365	Feb 18 05:50 PM
JOHN B SORENSON	Officer	Feb 18 '25	Proposed Sale	104.41	2,657	277,417		Feb 18 04:09 PM
DANIEL BRENNAN	Officer	Feb 18 '25	Proposed Sale	104.57	17,530	1,833,184		Feb 18 04:09 PM
Carruthers Wendy	Officer	Feb 14 '25	Proposed Sale	106.45	9,393	999,911		Feb 14 05:32 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 12 '25	Option Exercise	0.00	480	0	3,437	Feb 14 05:30 PM
Sorenson John Bradley	EVP, Global Operations	Feb 12 '25	Option Exercise	0.00	1,731	0	26,024	Feb 14 05:30 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 12 '25	Option Exercise	0.00	961	0	12,917	Feb 14 05:30 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 12 '25	Option Exercise	0.00	65	0	1,567	Feb 14 05:30 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 12 '25	Option Exercise	0.00	2,115	0	30,569	Feb 14 05:29 PM
Mahoney Michael F	Chairman, President & CEO	Feb 12 '25	Option Exercise	0.00	13,704	0	1,633,577	Feb 14 05:29 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 12 '25	Option Exercise	0.00	3,462	0	176,325	Feb 14 05:29 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 12 '25	Option Exercise	0.00	2,692	0	18,713	Feb 14 05:29 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 12 '25	Option Exercise	0.00	1,442	0	48,675	Feb 14 05:28 PM
Brennan Daniel J.	EVP and CFO	Feb 12 '25	Option Exercise	0.00	3,654	0	245,105	Feb 14 05:28 PM
JOHN B SORENSON	Officer	Feb 14 '25	Proposed Sale	106.31	1,201	127,678		Feb 14 04:02 PM
Sorenson John Bradley	EVP, Global Operations	Feb 12 '25	Sale	105.06	6,389	671,249	24,293	Feb 13 04:32 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 12 '25	Sale	105.06	13,022	1,368,073	28,454	Feb 13 04:32 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Dec 03 '24	Buy	90.29	50	4,515	148,168	Feb 13 04:32 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Dec 10 '24	Sale	89.97	20	1,799	148,148	Feb 13 04:32 PM
Brennan Daniel J.	EVP and CFO	Feb 12 '25	Option Exercise	16.31	15,087	246,069	256,538	Feb 13 04:31 PM
Brennan Daniel J.	EVP and CFO	Feb 12 '25	Sale	105.07	15,087	1,585,135	241,451	Feb 13 04:31 PM
LUDWIG EDWARD J	Director	Feb 11 '25	Sale	105.48	12,000	1,265,815	24,398	Feb 12 07:30 PM
DANIEL BRENNAN	Officer	Feb 12 '25	Proposed Sale	105.07	15,087	1,585,135		Feb 12 04:04 PM
JEFFREY B MIRVISS	Officer	Feb 12 '25	Proposed Sale	105.06	13,022	1,368,073		Feb 12 04:04 PM
JOHN B SORENSON	Officer	Feb 12 '25	Proposed Sale	105.06	6,389	671,249		Feb 12 04:03 PM
LUDWIG EDWARD J	Director	Feb 11 '25	Proposed Sale	105.48	12,000	1,265,816		Feb 11 05:42 PM
Sorenson John Bradley	EVP, Global Operations	Feb 07 '25	Sale	104.97	6,528	685,244	26,449	Feb 10 04:48 PM
JOHN B SORENSON	Officer	Feb 07 '25	Proposed Sale	104.97	6,528	685,244		Feb 07 04:02 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 03 '25	Option Exercise	24.81	17,313	429,493	22,815	Feb 04 07:00 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 03 '25	Sale	101.80	17,313	1,762,507	5,502	Feb 04 07:00 PM
ARTHUR C BUTCHER	Officer	Feb 03 '25	Proposed Sale	101.80	17,313	1,762,506		Feb 03 04:02 PM
Sorenson John Bradley	EVP, Global Operations	Jan 01 '25	Option Exercise	0.00	4,469	0	41,565	Jan 03 04:33 PM
Sorenson John Bradley	EVP, Global Operations	Jan 02 '25	Sale	90.02	4,119	370,792	35,319	Jan 03 04:33 PM
Sorenson John Bradley	EVP, Global Operations	Jan 03 '25	Sale	89.86	2,342	210,449	32,977	Jan 03 04:33 PM
Mahoney Michael F	Chairman, President & CEO	Jan 01 '25	Option Exercise	0.00	57,121	0	1,578,326	Jan 03 04:32 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Jan 01 '25	Option Exercise	0.00	10,430	0	38,884	Jan 03 04:32 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Jan 03 '25	Sale	89.86	7,152	642,658	28,454	Jan 03 04:32 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jan 01 '25	Option Exercise	0.00	13,907	0	162,025	Jan 03 04:32 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Jan 01 '25	Option Exercise	0.00	8,940	0	9,918	Jan 03 04:32 PM
Brown Vance R	SVP, GC and Corp. Secretary	Jan 01 '25	Option Exercise	0.00	6,456	0	40,866	Jan 03 04:32 PM
Brennan Daniel J.	EVP and CFO	Jan 01 '25	Option Exercise	0.00	14,901	0	238,822	Jan 03 04:32 PM
Brennan Daniel J.	EVP and CFO	Jan 03 '25	Sale	89.86	9,689	870,636	223,921	Jan 03 04:32 PM
JEFFREY B MIRVISS	Officer	Jan 03 '25	Proposed Sale	89.86	7,152	642,657		Jan 03 04:03 PM
JOHN B SORENSON	Officer	Jan 03 '25	Proposed Sale	89.86	2,342	210,449		Jan 03 04:02 PM
DANIEL BRENNAN	Officer	Jan 03 '25	Proposed Sale	89.86	9,689	870,635		Jan 03 04:00 PM
JOHN B SORENSON	Officer	Jan 02 '25	Proposed Sale	90.02	4,119	370,792		Jan 02 04:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BSX

Boston Scientific Corp

Upgrade your FINVIZ experience